Gilead to start testing Remdesivir in children after success with adults

National

One vial of the drug Remdesivir lies during a press conference about the start of a study with the Ebola drug Remdesivir in particularly severely ill patients at the University Hospital Eppendorf (UKE) in Hamburg, northern Germany on April 8, 2020, amidst the new coronavirus COVID-19 pandemic. (Photo by Ulrich Perrey / POOL / AFP) (Photo by ULRICH PERREY/POOL/AFP via Getty Images)

FOSTER CITY, California — A drug that showed positive results in treating adult coronavirus patients will now be tested on children, according to researchers.

Researchers said they will start advanced trials of “Remdesivir” in 50 pediatric patients.

The drug’s maker, Gilead Sciences, said the trials will be done in the United States and Europe.

They will involve children with moderate to severe cases of COVID-19, and the goal is to determine whether the drug is safe and how well it could work.

Remdesivir is the only drug that received emergency approval in the U.S. for treating coronavirus infections.

Earlier studies showed it could speed up the recovery of some adult patients.

CNN Newsource contributed to this article.

Copyright 2020 Nexstar Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

News Highlights

More News Highlights

Don't Miss

Event Calendar